Skip to main content

Find Clinical Trials

Home
Conditions
Primary Peritoneal Cavity Cancer

Clinical trial condition

Primary Peritoneal Cavity Cancer

Explore clinical trials studying Primary Peritoneal Cavity Cancer. Study availability and eligibility vary by location and protocol.

95 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Primary Peritoneal Cavity Cancer trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

NCT00041041

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer

NCT00003136

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

NCT00002734

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

View Trial Details

Completed

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

NCT00004934

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: St. Mary's/Duluth Clinic Cancer Center Duluth, Minnesota, United States

U.Z. Gasthuisberg Leuven, Belgium

Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View all 18 locations

View Trial Details

Completed

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

NCT00081276

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Gynecologic Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00036751

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +20 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00016289

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00003358

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

NCT00107445

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +37 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details